WeTrials
Completed

Interventional, Open-label Trial, Investigating the Effectiveness of Eptinezumab in Participants With Migraine and Previous Inadequate Response to CGRP-targeting Therapies

What is this study?

This study is testing a medication called eptinezumab to see if it helps reduce migraines and improve quality of life. It is especially designed for people who have tried other similar migraine prevention treatments without success.

Who can participate?

You might be able to join if you have had migraines for at least a year, experience 8 or more migraine days a month, and have tried a previous prevention medication that did not work well enough for you.

What will happen?

Participants will receive the study medication through an IV infusion to help prevent migraines. Throughout the study, your symptoms and overall well-being will be closely monitored by the research team.

Where and when?

This study has trial locations in places like Phoenix, Arizona, and Little Rock, Arkansas. The study has already been completed.

Key Points
  • 1Tests the medication eptinezumab for migraine prevention
  • 2For adults whose previous migraine treatments did not work
  • 3Medication is given through an IV

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Migraine

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.